{"id":"https://openalex.org/W4310125533","doi":"https://doi.org/10.1182/blood-2022-158068","title":"Treatment Patterns and Outcomes of Patients with Primary or Secondary Acute Myeloid Leukemia By Type of Site (Academic or Community/Government): A CONNECT\u00ae Myeloid Registry Study","display_name":"Treatment Patterns and Outcomes of Patients with Primary or Secondary Acute Myeloid Leukemia By Type of Site (Academic or Community/Government): A CONNECT\u00ae Myeloid Registry Study","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310125533","doi":"https://doi.org/10.1182/blood-2022-158068"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-158068","doi":"https://doi.org/10.1182/blood-2022-158068","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-158068","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074629157","display_name":"Bart Lee Scott","orcid":"https://orcid.org/0000-0001-9620-7839","observed_orcids":["https://orcid.org/0000-0001-9620-7839"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bart L. Scott","raw_affiliation_strings":["1Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049400849","display_name":"Michael Robert Savona","orcid":"https://orcid.org/0000-0003-3763-5504","observed_orcids":["https://orcid.org/0000-0003-3763-5504"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael R. Savona","raw_affiliation_strings":["2Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012863731","display_name":"Gail J. Roboz","orcid":"https://orcid.org/0000-0002-0384-3658","observed_orcids":["https://orcid.org/0000-0002-0384-3658"]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gail J. Roboz","raw_affiliation_strings":["3Weill Cornell Medicine and New York-Presbyterian Hospital, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Weill Cornell Medicine and New York-Presbyterian Hospital, New York, NY","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084409602","display_name":"Karen P. Seiter","orcid":"https://orcid.org/0000-0003-3838-7901","observed_orcids":["https://orcid.org/0000-0003-3838-7901"]},"institutions":[{"id":"https://openalex.org/I181190671","display_name":"New York Medical College","ror":"https://ror.org/03dkvy735","country_code":"US","type":"education","lineage":["https://openalex.org/I181190671"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Seiter","raw_affiliation_strings":["4New York Medical College, Valhalla, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4New York Medical College, Valhalla, NY","institution_ids":["https://openalex.org/I181190671"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032549755","display_name":"Daniel Aaron Pollyea","orcid":"https://orcid.org/0000-0001-6519-4860","observed_orcids":["https://orcid.org/0000-0001-6519-4860"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel A. Pollyea","raw_affiliation_strings":["5University of Colorado, Aurora, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5University of Colorado, Aurora, CO","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077880353","display_name":"Irene S. DeGutis","orcid":"https://orcid.org/0000-0003-3190-5227","observed_orcids":["https://orcid.org/0000-0003-3190-5227"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irene S. DeGutis","raw_affiliation_strings":["6Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025352490","display_name":"Pavel Kiselev","orcid":"https://orcid.org/0000-0002-6456-6412","observed_orcids":["https://orcid.org/0000-0002-6456-6412"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pavel Kiselev","raw_affiliation_strings":["6Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007481038","display_name":"Edward Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward Yu","raw_affiliation_strings":["6Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049387929","display_name":"Ali McBride","orcid":"https://orcid.org/0000-0002-9430-4675","observed_orcids":["https://orcid.org/0000-0002-9430-4675"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ali McBride","raw_affiliation_strings":["6Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005816773","display_name":"Willem Heydendael","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Willem Heydendael","raw_affiliation_strings":["6Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050556099","display_name":"Harry Paul Erba","orcid":"https://orcid.org/0000-0003-1093-2189","observed_orcids":["https://orcid.org/0000-0003-1093-2189"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harry P. Erba","raw_affiliation_strings":["7Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Duke University, Durham, NC","institution_ids":["https://openalex.org/I170897317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.25973163,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"140","issue":"Supplement 1","first_page":"8923","last_page":"8925"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14078","display_name":"Multiple and Secondary Primary Cancers","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9800000190734863},{"id":"https://openalex.org/keywords/secondary-acute-myeloid-leukemia","display_name":"secondary acute myeloid leukemia","score":0.9200000166893005},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9079999923706055},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9229999780654907},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9290000200271606},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9110000133514404},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8939999938011169},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.8259999752044678},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.6029999852180481}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7346712350845337},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5724868178367615},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5094926953315735},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.4793992042541504},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4704122841358185},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4601019620895386},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.41555696725845337},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.10875612497329712}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1182/blood-2022-158068","doi":"https://doi.org/10.1182/blood-2022-158068","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-158068","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmh:oai:touroscholar.touro.edu:nymc_fac_abstracts-1711","doi":null,"is_oa":false,"landing_page_url":"https://touroscholar.touro.edu/nymc_fac_abstracts/747","pdf_url":null,"source":{"id":"https://openalex.org/S4377196437","display_name":"Touro Scholar (Touro College)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I200437953","host_organization_name":"Touro College","host_organization_lineage":["https://openalex.org/I200437953"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"NYMC Faculty Conference Abstracts","raw_type":"abstract"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"No poverty","id":"https://metadata.un.org/sdg/1","score":0.6800000071525574}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4405054882","https://openalex.org/W4389247601","https://openalex.org/W2979745703","https://openalex.org/W4389232147","https://openalex.org/W4405738562","https://openalex.org/W4417016214","https://openalex.org/W7093122489","https://openalex.org/W4407295726","https://openalex.org/W2593131904","https://openalex.org/W4405047222"],"abstract_inverted_index":{"Introduction":[0],"Up":[1],"to":[2,130,152,175,505,594,646],"30%":[3],"of":[4,53,59,66,69,103,122,138,154,160,177,185,215,223,232,442,512,596,604,631,651,685,694],"acute":[5],"myeloid":[6],"leukemias":[7],"(AML)":[8],"evolve":[9],"from":[10,128,135],"prior":[11],"hematologic":[12],"disorders":[13],"and":[14,39,56,76,92,167,190,210,217,258,277,315,330,340,354,361,413,573,592,659,713],"are":[15,503,614],"classified":[16,111],"as":[17,112,182],"secondary":[18,70,85,117,241,264,274,289,303,331,414,437,494,528,628,688],"AML.":[19,131],"Secondary":[20],"AML":[21,46,83,86,118,139,233,256,265,295,329,332,397,415,435,438,519,529,607,626,629,689],"is":[22,622],"traditionally":[23],"associated":[24],"with":[25,50,81,204,229,293,302,327,388,433,460,483,517,527,542,606,616,680,697],"worse":[26],"prognosis":[27],"than":[28,300,525],"de":[29],"novo,":[30],"or":[31,106,116,126,157,283,578,636,687],"primary,":[32],"AML,":[33,71,237,242,272,275,287,290,488,495],"resulting":[34],"in":[35,78,88,94,148,195,226,253,262,355,378,381,431,608,624,639,672,674,710],"inferior":[36],"response":[37],"rates":[38],"poorer":[40],"survival.":[41],"The":[42,668],"treatment":[43,74,711],"landscape":[44],"for":[45,206,325,394,507,700],"has":[47],"evolved":[48],"recently":[49],"the":[51,57,67,95,136,143,227,254,263,609,692,698],"introduction":[52],"venetoclax":[54],"(VEN)":[55],"availability":[58],"targeted":[60],"agents.":[61],"To":[62],"better":[63],"understand":[64],"evolution":[65],"management":[68],"we":[72],"evaluated":[73,147,199],"patterns":[75,712],"outcomes":[77,603],"patients":[79],"(pts)":[80],"primary":[82,115,255,294,328,396,434,487,518,625,686],"vs":[84,399,407,421,436,449,465,491,498,535,547,566,581,627],"treated":[87,280,333,383,390,575],"real-world":[89],"clinical":[90],"practice":[91],"enrolled":[93],"CONNECT\u00ae":[96,610],"Myeloid":[97,611],"Disease":[98,612],"Registry":[99,228,613],"(NCT01688011)":[100],"by":[101,142,560],"type":[102,153,214],"site":[104,155,650],"(academic":[105,156,398],"community/government).":[107],"Methods":[108],"Pts":[109,292],"were":[110,234,249,269,279,556],"having":[113],"either":[114],"based":[119],"on":[120],"history":[121],"myelodysplastic":[123],"syndrome":[124],"(MDS)":[125],"progression":[127],"MDS":[129],"Overall":[132],"survival":[133,299],"(OS)":[134],"date":[137],"diagnosis,":[140],"estimated":[141],"Kaplan-Meier":[144],"method,":[145],"was":[146,198,311,337,358,374,439,475,599],"each":[149],"group":[150,257],"according":[151],"community/government),":[158],"utilization":[159],"allogeneic":[161],"hematopoietic":[162],"stem":[163],"cell":[164],"transplantation":[165],"(alloHSCT),":[166],"tumor":[168],"protein":[169],"p53":[170],"(TP53)":[171],"mutational":[172],"status.":[173],"Time":[174],"adoption":[176,595,662],"a":[178,201,230],"VEN-based":[179,186,554,597],"therapy,":[180],"defined":[181],"first":[183],"use":[184],"therapy":[187],"following":[188],"Food":[189],"Drug":[191],"Administration":[192],"(FDA)":[193],"approval":[194],"this":[196],"setting,":[197],"using":[200],"Cox":[202],"model":[203],"factors":[205],"age":[207],"(<":[208],"75":[209,212,564,568],"\u2265":[211,563],"y),":[213],"site,":[216],"geographic":[218,590],"region.":[219],"Results":[220],"A":[221],"total":[222],"891":[224],"pts":[225,268,301,326,382,389,432,478,516,526,561,605,633,675,681,696],"diagnosis":[231],"assessed":[235],"(primary":[236,271,286],"n":[238,243],"=":[239,244,470,552,585],"676;":[240],"215).":[245],"Median":[246,323,620],"(range)":[247],"ages":[248],"70":[250],"(55-97)":[251],"y":[252,261,565,569],"74":[259],"(19-93)":[260],"group.":[266],"Most":[267],"male":[270],"61.6%;":[273],"61.5%)":[276],"most":[278],"at":[281,334,384,391,576,665],"community":[282,577,666],"government":[284,579],"centers":[285,336,357,386,393,580,583],"60.2%;":[288],"66.0%).":[291],"had":[296,520],"significantly":[297,521],"longer":[298,428,522,623],"AML;":[304],"median":[305,379,429,473,523],"OS":[306,324,380,430,474,524,621,673],"(95%":[307],"confidence":[308],"interval":[309],"[CI])":[310],"15.6":[312],"(13.6-17.4)":[313],"mo":[314,339,360,403,409,417,423,448,463,467,490,497,533,537,545,549],"5.1":[316,422],"(3.6-6.7)":[317],"mo,":[318,342,363],"respectively":[319,343,364],"(P":[320,570,584],"<":[321,352,371,458,540,567,571],"0.001).":[322,372],"academic":[335,385,582],"17.0":[338,402],"5.6":[341],"(hazard":[344],"ratio":[345],"[HR]":[346],"[95%":[347,366,404,418,453],"CI],":[348,367,454],"0.41":[349],"[0.30-0.54],":[350],"P":[351,370,457,469,539,551],"0.001)":[353,572],"community/government":[356,392,400],"14.1":[359,408],"5.2":[362],"(HR":[365],"0.53":[368,455],"[0.43-0.66],":[369],"There":[373],"no":[375,587],"significant":[376],"difference":[377],"compared":[387,482,679],"both":[395],"centers:":[401],"CI,":[405,419],"14.7-20.7]":[406],"[11.0-16.9];":[410],"Figure":[411,425],"1A)":[412],"(5.0":[416],"3.0-7.2]":[420],"[3.7-7.3];":[424],"1B).":[426],"Significantly":[427],"observed":[440,476],"regardless":[441,630,684],"alloHSCT":[443,481,635],"status":[444],"(no":[445,530],"alloHSCT:":[446,461,486],"11.7":[447],"4.5":[450],"mo;":[451,493,500],"HR":[452],"[0.44-0.64],":[456],"0.001;":[459,541],"64.3":[462],"[35.8-NC]":[464],"24.9":[466,496],"[6.8-48.9],":[468],"0.002].":[471],"Longer":[472],"among":[477],"who":[479],"received":[480],"those":[484,574],"without":[485,682],"41.1":[489],"12.8":[492],"4.4":[499],"additional":[501],"analyses":[502],"warranted":[504],"account":[506],"immortal":[508],"time":[509,593],"bias.":[510],"Regardless":[511],"TP53":[513],"mutation":[514],"status,":[515],"mutation:":[531,543],"22.0":[532],"[17.6-26.1]":[534],"6.2":[536],"[2.5-12.6],":[538],"8.8":[544],"[3.9-14.2]":[546],"3.8":[548],"[1.4-6.8],":[550],"0.014).":[553],"therapies":[555,598],"adopted":[557],"more":[558],"quickly":[559],"aged":[562],"0.045);":[586],"association":[588],"between":[589],"region":[591],"observed.":[600],"Conclusions":[601],"Overall,":[602],"consistent":[615],"previously":[617],"reported":[618],"outcomes.":[619,714],"whether":[632],"receive":[634],"have":[637],"mutations":[638],"TP53.":[640],"This":[641],"analysis":[642],"suggests":[643],"that":[644,660],"contrary":[645],"commonly":[647],"held":[648],"perceptions,":[649],"care":[652],"does":[653],"not":[654],"affect":[655],"overall":[656],"pt":[657],"outcome":[658],"VEN":[661],"occurs":[663],"sooner":[664],"centers.":[667],"clinically":[669],"meaningful":[670],"increase":[671],"receiving":[676],"alloHSCT,":[677,683],"when":[678],"further":[690,705],"emphasizes":[691],"importance":[693],"providing":[695],"opportunity":[699],"transplant.":[701],"These":[702],"observations":[703],"merit":[704],"study":[706],"into":[707],"potential":[708],"differences":[709]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2022-11-30T00:00:00"}